BACKGROUND AND PURPOSE: To assess the impact of a stroke unit (SU) on acute phase treatment when compared to a conventional general ward treatment (GW). METHOD:Seventy-four patients with acute stroke were randomized between a SU and conventional general ward (GW). We compared both groups regarding the length of hospital stay, lethality and functional and clinical status within 6 months, using the Scandinavian scale and Barthel index. RESULTS:Thirty-five and thirty-nine patients were allocated at SU and GW, respectively. Lethality on the 10th day at SU and GW achieved 8.5% and 12.8% respectively (p= 0.41), whereas 30-days mortality rates achieved 14.2% and 28.2% (p= 0.24), 17.4% and 28.7% on the 3rd month (p= 0.39), and 25.7% and 30.7% on the 6th month (p= 0.41). Thirty-day survival curve achieved 1.8 log rank (p= 0.17), with a trend for lower lethality in the SU. In order to save one death in 6 months in SU, NNT (the number need to treat) was 20; to get one more home independent patient NNT was 15. No significant difference was found between the length of hospital stay and morbidity. CONCLUSION: No significant benefit was found in SU patients compared to GW group. However,an evident benefit in absolute numbers was observed in lethality, survival curve and NNT in thirty days period after stroke. Further collaborative studies or incresead number of patients are required to define the role of SU.
RCT Entities:
BACKGROUND AND PURPOSE: To assess the impact of a stroke unit (SU) on acute phase treatment when compared to a conventional general ward treatment (GW). METHOD: Seventy-four patients with acute stroke were randomized between a SU and conventional general ward (GW). We compared both groups regarding the length of hospital stay, lethality and functional and clinical status within 6 months, using the Scandinavian scale and Barthel index. RESULTS: Thirty-five and thirty-nine patients were allocated at SU and GW, respectively. Lethality on the 10th day at SU and GW achieved 8.5% and 12.8% respectively (p= 0.41), whereas 30-days mortality rates achieved 14.2% and 28.2% (p= 0.24), 17.4% and 28.7% on the 3rd month (p= 0.39), and 25.7% and 30.7% on the 6th month (p= 0.41). Thirty-day survival curve achieved 1.8 log rank (p= 0.17), with a trend for lower lethality in the SU. In order to save one death in 6 months in SU, NNT (the number need to treat) was 20; to get one more home independent patientNNT was 15. No significant difference was found between the length of hospital stay and morbidity. CONCLUSION: No significant benefit was found in SUpatients compared to GW group. However,an evident benefit in absolute numbers was observed in lethality, survival curve and NNT in thirty days period after stroke. Further collaborative studies or incresead number of patients are required to define the role of SU.
Authors: Carolina Cincura; Octavio M Pontes-Neto; Iuri S Neville; Henrique F Mendes; Daniela F Menezes; Débora C Mariano; Issana F Pereira; Larissa A Teixeira; Pedro A P Jesus; Danilo C L de Queiroz; Davidson F Pereira; Elen Pinto; João P Leite; Antonio A Lopes; Jamary Oliveira-Filho Journal: Cerebrovasc Dis Date: 2008-11-28 Impact factor: 2.762
Authors: Marcos C Lange; Tiago F S de Araujo; Luiz F T Ferreira; Renata D P Ducci; Edison M Novak; Francisco M B Germiniani; Viviane F Zetola Journal: Neurohospitalist Date: 2016-10-04
Authors: Gláucia Maria Moraes de Oliveira; Luisa Campos Caldeira Brant; Carisi Anne Polanczyk; Andreia Biolo; Bruno Ramos Nascimento; Deborah Carvalho Malta; Maria de Fatima Marinho de Souza; Gabriel Porto Soares; Gesner Francisco Xavier Junior; M Julia Machline-Carrion; Marcio Sommer Bittencourt; Octavio M Pontes Neto; Odilson Marcos Silvestre; Renato Azeredo Teixeira; Roney Orismar Sampaio; Thomaz A Gaziano; Gregory A Roth; Antonio Luiz Pinho Ribeiro Journal: Arq Bras Cardiol Date: 2020-09 Impact factor: 2.667
Authors: Norberto L Cabral; Adriana Conforto; Pedro S C Magalhaes; Alexandre L Longo; Carla H C Moro; Hamilton Appel; Paulo Wille; Vivian Nagel; Vanessa Venancio; Adriana C Garcia; Suleimy Cristina Mazin; Anderson R R Goncalves Journal: eNeurologicalSci Date: 2016-04-14
Authors: N L Cabral; A R R Gonçalves; A L Longo; C H C Moro; G Costa; C H Amaral; M V Souza; J Eluf-Neto; L Augusto M Fonseca Journal: J Neurol Neurosurg Psychiatry Date: 2009-01-15 Impact factor: 10.154
Authors: Gustavo José Luvizutto; Tamiris Aparecida Monteiro; Gabriel Braga; Octavio Marques Pontes-Neto; Luiz Antônio de Lima Resende; Rodrigo Bazan Journal: Cerebrovasc Dis Extra Date: 2012-12-29